Johnson & Johnson (JNJ): EPS (Basic)
$11.13
Year ended 2025-12-28
+17.7%
3-year compound annual growth
+14.8%
5-year compound annual growth
+7.2%
10-year compound annual growth
| Period ended | EPS (Basic) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-28 | $11.13 | +90.6% | 2026-02-11, From 2024-12-30 |
| 2024-12-29 | $5.84 | -57.9% | 2026-02-11, From 2024-01-01 |
| 2023-12-31 | $13.88 | +103.2% | 2026-02-11, From 2023-01-02 |
| 2023-01-01, Fiscal 2022 | $6.83 | -13.9% | 2025-02-13, From 2022-01-03 |
| 2022-01-02, Fiscal 2021 | $7.93 | +41.9% | 2024-02-16, From 2021-01-04 |
| 2021-01-03, Fiscal 2020 | $5.59 | -2.3% | 2023-02-16, From 2019-12-30 |
| 2019-12-29 | $5.72 | +0.4% | 2022-02-17, From 2018-12-31 |
| 2018-12-30 | $5.70 | n/m | 2021-02-22, From 2018-01-01 |
| 2017-12-31 | $0.48 | -92.1% | 2020-02-18, From 2017-01-02 |
| 2017-01-01, Fiscal 2016 | $6.04 | +8.6% | 2019-02-20, From 2016-01-04 |
| 2016-01-03, Fiscal 2015 | $5.56 | -4.1% | 2018-02-21, From 2014-12-29 |
| 2014-12-28 | $5.80 | +17.9% | 2017-02-27, From 2013-12-30 |
| 2013-12-29 | $4.92 | +24.9% | 2016-02-24, From 2012-12-31 |
| 2012-12-30 | $3.94 | +11.3% | 2015-02-24, From 2012-01-02 |
| 2012-01-01, Fiscal 2011 | $3.54 | -27.0% | 2014-02-21, From 2011-01-03 |
| 2011-01-02, Fiscal 2010 | $4.85 | +9.0% | 2013-02-22, From 2010-01-04 |
| 2010-01-03, Fiscal 2009 | $4.45 | -3.7% | 2012-02-23, From 2008-12-29 |
| 2008-12-28 | $4.62 | +25.9% | 2011-02-25, From 2007-12-31 |
| 2007-12-30 | $3.67 | n/a | 2010-03-01, From 2007-01-01 |
EPS (Basic) at similar companies
| Company | Year ended | EPS (Basic) | Change YoY |
|---|---|---|---|
| Johnson & Johnson (JNJ) | 2025-12-28 | $11.13 | +90.6% |
| Eli Lilly & Co (LLY) | 2025-12-31 | $23.00 | +95.6% |
| Merck & Co., Inc. (MRK) | 2025-12-31 | $7.30 | +8.0% |
| Pfizer Inc (PFE) | 2025-12-31 | $1.37 | -3.5% |
| AbbVie Inc. (ABBV) | 2025-12-31 | $2.37 | -1.3% |
| Bristol Myers Squibb Co (BMY) | 2025-12-31 | $3.47 | n/m |
| Abbott Laboratories (ABT) | 2025-12-31 | $3.73 | -51.4% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $1.23 | n/m |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $43.07 | +5.3% |
Compare JNJ, LLY, MRK, PFE side by side · Screen every company in Pharmaceutical Preparations ↗